• Motor neurone disease onset delayed by AI-discovered drug europeanpharmaceuticalreview
    May 26, 2017
    The Sheffield Institute for Translational Neuroscience (SITraN) announced that its research into a drug candidate, discovered by British artificial intelligence firm BenevolentAI, has delivered positive results.
PharmaSources Customer Service